Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Couturier, , Martine,
DOB: 13-NOV-1961 (Age: 63)
Gender: female
Address:
458, rue de Bègue
03110 Boutin (France)
ID: 6614-983327-0 (ECI)
Report
Date: 13-JUL-2018
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Centre hospitalier Jacques Lacarin
Boulevard Denière 1
03200 Vichy (France)
Specimen
Collected: 13-JUL-2018

Chemistry

Test 13-JUL-2018 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 7.0 H 4 - 6 %
Glucose [Mass/volume] in Blood 111.4 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 12.0 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 8.9 8.5 - 10.4 mg/dL
Sodium [Moles/volume] in Blood 143.7 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.0 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 101.1 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.1 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 207.3 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 189.6 H 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 111.8 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 57.7 40 - 100 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 5.7 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated HbA1c, indicating suboptimal long-term glycemic control (diabetes). Cholesterol and triglycerides are also elevated, suggesting increased cardiovascular risk. Renal function, electrolytes, and urine microalbumin/creatinine ratio are within normal limits. Recommend optimization of diabetes and lipid management; no current evidence of renal impairment.